Literature DB >> 3402576

Policies for immunization against rubella in European countries.

I De la Mata1, P De Wals.   

Abstract

In 1986 a survey on immunization policies against rubella was conducted in 17 European countries. A questionnaire was sent to each Ministry of Health and selected practitioners, requesting information on official policy for vaccination against rubella, level of policy decision, immunization strategy, target groups, current recommendations for vaccination, measures taken to facilitate vaccine uptake, vaccine strains used and legislation concerning abortion. A policy for the prevention of congenital rubella is explicitly defined in 16 countries (in 12 at a national level, in 3 at a regional level and in one at both levels). In Greece only, no official policy has been defined, although the practice is to vaccinate infants over 15 months of age and girls by 9-11 years of age. There are 3 countries maintaining the selective strategy of vaccinating teenage girls, but in 8 countries this strategy changed to a mass vaccination of young infants. In 5 other countries an approach combining both mass immunization and selective vaccination is adopted. This situation of different strategies between countries in Europe could have a deleterious effect for young migrants or travelling pregnant women and could reduce the effectiveness of programmes for prevention of congenital rubella syndrome. Harmonization of immunization policies and of recommendations for vaccine administration is advisable. The mass vaccination of all young children combined with systematic revaccination either of all children or of teenage girls is probably the most effective approach for elimination of congenital rubella syndrome in Europe.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3402576     DOI: 10.1007/bf00144747

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Rubella and congenital rubella syndrome--United States, 1984-1985.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-03-07       Impact factor: 17.586

2.  Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.

Authors:  S A Plotkin; J D Farquhar; P L Ogra
Journal:  JAMA       Date:  1973-08-06       Impact factor: 56.272

3.  Elimination of diseases from Europe through use of vaccines.

Authors:  B D Bytchenko; S Dittmann
Journal:  Dev Biol Stand       Date:  1986

4.  Control of congenital rubella syndrome by mass vaccination.

Authors:  R M Anderson; B T Grenfell
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

5.  Vaccination against rubella and measles: quantitative investigations of different policies.

Authors:  R M Anderson; R M May
Journal:  J Hyg (Lond)       Date:  1983-04

6.  Universal immunization to interrupt rubella.

Authors:  K J Bart; W A Orenstein; S R Preblud; A R Hinman
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

7.  Rubella in the United Kingdom, 1970-1983.

Authors:  J O Tobin; S Sheppard; R W Smithells; A Milton; N Noah; D Reid
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

8.  Selective immunization: protection of the individual.

Authors:  J A Dudgeon
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

9.  Theoretical aspects of rubella vaccination strategies.

Authors:  E G Knox
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

10.  Strategy for rubella vaccination.

Authors:  E G Knox
Journal:  Int J Epidemiol       Date:  1980-03       Impact factor: 7.196

View more
  4 in total

Review 1.  Rubella in Europe.

Authors:  A Galazka
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Incidence of congenital rubella syndrome in 19 regions of Europe in 1980-1986.

Authors:  I De la Mata; P De Wals; H Dolk; M F Lechat; R Beckers; I Borlee; F Lys; R Zori; J Goujard; C Stoll
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

Review 3.  Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review.

Authors:  T Panagiotopoulos; I Antoniadou; E Valassi-Adam
Journal:  BMJ       Date:  1999-12-04

4.  Seroprevalence to some TORCH agents in a Sicilian female population of fertile age.

Authors:  F Condorelli; G Scalia; A Stivala; M C Costanzo; A D Adragna; C Franceschino; M G Santagati; P M Furneri; A Marino; A Castro
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.